FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
0.9000
-0.0500 (-5.26%)
At close: Mar 31, 2025, 4:00 PM
0.9657
+0.0656 (7.29%)
Pre-market: Apr 1, 2025, 5:50 AM EDT
FibroBiologics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
10
Market Cap
33.43M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFBLG News
- 13 hours ago - FibroBiologics Reports Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 days ago - FibroBiologics Announces 2025 Annual Meeting of Stockholders - GlobeNewsWire
- 10 days ago - FibroBiologics to Present at The German-Nordic Joint Extracellular Matrix Meeting - GlobeNewsWire
- 27 days ago - FibroBiologics Files Patent For Novel Approach to Modulate Mitochondrial Activity Using Fibroblast-based Therapeutics - GlobeNewsWire
- 4 weeks ago - FibroBiologics and Charles River Announce Completion and Release of CYWC628 Master Cell Bank for the Manufacturing of Fibroblast Cell-based Wound Healing Therapeutic - GlobeNewsWire
- 7 weeks ago - FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates - GlobeNewsWire
- 3 months ago - FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing - GlobeNewsWire
- 3 months ago - D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - GlobeNewsWire